| 期刊全称 | Nanomedicine | |||||||||||||||||||||||||||||||||||||||
| 期刊缩写 | NANOMEDICINE-UK | |||||||||||||||||||||||||||||||||||||||
|
涉及主题
（科研通AI识别） |
||||||||||||||||||||||||||||||||||||||||
| 期刊介绍 | Medicine has developed throughout time but has remained forever concerned with the maintenance of health and thus the science of prevention and alleviation, and ultimately curing, of disease. To continue its development in new directions, medicine is now looking to nanomedicine, an emerging scientific specialty born from nanotechnology, which has grown up in the fields of engineering, physics, chemistry and biotechnology, and is now moving into medicine, with huge potential for expansion and development over the next decade and beyond. As our knowledge of the human body continues to improve, nanotechnology will be developed to monitor, repair and control human biological systems at the molecular level. This will offer unique opportunities for developing new therapeutic approaches to diagnose, prevent, treat and eradicate life-threatening diseases and conditions (such as cancer and diabetes), as well as resolving pain and improving medical techniques (such as bone repair and surgical techniques), through various novel nanotechnological approaches. Nanomedicine (ISSN 1743-5889) is a uniquely medicine-focused journal, addressing the important challenges and advances in medical nanoscale-structured material and devices, biotechnology devices and molecular machine systems and nanorobotics, delivering this essential information in concise, clear and attractive article formats. The journal is a valuable information source for all players in the field – academic, industrial and clinical researchers, pharmaceutical and biotechnology companies, regulatory authorities and others across the scientific community. The nanomedicine field is still in its infancy, however, in the next few years there are likely to be further exciting developments across medical science, engineering, chemistry and physics. Diverse researchers working together under the nanomedicine umbrella will produce findings with potential medical uses: preventing, diagnosing and treating human diseases, as well as relieving pain. Nanomedicine will provide a critical overview of these advances as they unfold, helping to shape the future of medicine in this exciting era. | |||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||
| 期刊ISSN | print: 1743-5889on-line: 1748-6963 | |||||||||||||||||||||||||||||||||||||||
| 2026最新影响因子 (2026年6月17日发布) 与上一年的差值 |
4.6↑ 0.7 | |||||||||||||||||||||||||||||||||||||||
| 历年影响因子 |
|
|||||||||||||||||||||||||||||||||||||||
| 历年发表/被引量 （科研通AI通过大数据分析） 最后更新日期：2026-07-16 |
|
|||||||||||||||||||||||||||||||||||||||
| h-index（2021） | 93 | |||||||||||||||||||||||||||||||||||||||
| 自引率 | 4.30% | |||||||||||||||||||||||||||||||||||||||
| 涉及的研究领域 | 医学-纳米科技 | |||||||||||||||||||||||||||||||||||||||
| 2026年新锐分区 （2026年3月24日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 2026年WOS期刊分区 （2026年6月17日发布） |
JCR学科分类
JCI学科分类
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2025年分区 （2025年3月20日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院2024年分区 （2023年12月27日发布） |
|
|||||||||||||||||||||||||||||||||||||||
| 中科院《国际期刊预警名单（试行）》名单 |
2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 |
|||||||||||||||||||||||||||||||||||||||
| 期刊主页 | ||||||||||||||||||||||||||||||||||||||||
| 投稿网址 | http://www.futuremedicine.com/page/submitarticle | |||||||||||||||||||||||||||||||||||||||
| 编辑部地址 | FUTURE MEDICINE LTD, UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, ENGLAND, N3 1QB | |||||||||||||||||||||||||||||||||||||||
| 出版商 | Future Medicine Ltd. | |||||||||||||||||||||||||||||||||||||||
| 出版国家（地区） | ENGLAND | |||||||||||||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||||||||||||||||||||
| 创刊年份 | 2006 | |||||||||||||||||||||||||||||||||||||||
| 每年出版文章数 | 149 | |||||||||||||||||||||||||||||||||||||||
| Gold OA文章占比 | 5.94% | |||||||||||||||||||||||||||||||||||||||
| 原创研究文献占比 （排除综述） |
65.17% | |||||||||||||||||||||||||||||||||||||||
| SCI收录类型 |
Science Citation Index Expanded (SCIE) Scopus (CiteScore) |
|||||||||||||||||||||||||||||||||||||||
| PubMed链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1743-5889%5BISSN%5D | |||||||||||||||||||||||||||||||||||||||
| 平均审稿周期 | 网友分享经验： 平均6.0个月 |
|||||||||||||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约25% |
|||||||||||||||||||||||||||||||||||||||
| 相关链接 |
您可以在上述网站查看该期刊的网友互动，及期刊影响力的其它指标。
|
|||||||||||||||||||||||||||||||||||||||
皖公网安备34019202002308
